Oncolytics KOL Webinar on Data from the Randomized Phase 2 BRACELET-1 Trial in HR+ / HER2- Metastatic Breast Cancer Being Presented at the Upcoming ASCO Annual Meeting
About The Event
Join us for a virtual KOL event with Oncolytics Biotech, featuring Martine J. Piccart, MD, PhD (Université Libre de Bruxelles (ULB), Belgium), Richard Vile, PhD (Mayo Clinic), and Aleix Prat, MD, PhD (University of Barcelona).
During the event, Drs. Piccart, Vile, and Prat, along with the Oncolytics management team, will discuss the current treatment landscape for HR+/HER2- metastatic breast cancer, as well as results from the randomized Phase 2 BRACELET-1 study, which will be showcased in an oral presentation at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.
A live question and answer session will follow the formal presentations.